YSELTY (Theramex Australia Pty Ltd)
Product name
YSELTY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
174 (175 working days)
Active ingredients
linzagolix choline
Registration type
NCE/NBE
Indication
YSELTY is indicated for the management of heavy menstrual bleeding (HMB) associated with uterine fibroids.